Evidence map›Paper›PMID 42841318›Full record

ArticleBioMed research international2026

Illuminating the Co-Phosphoregulatory Network of the Dark Kinase STK10 by Omics Approaches.

Vaishnavi Gopalakrishnan, Amal Fahma, Althaf Mahin, Leona Dcunha, Athira Perunelly Gopalakrishnan, Samseera Ummar, Rajesh Raju, Sowmya Soman

Abstract read
In one paragraph

Article in BioMed research international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Vaishnavi GopalakrishnanCentre for Integrative Omics Data Science (CIODS), Yenepoya (Deemed to be University), Mangalore, Karnataka, India.ORCID https://orcid.org/0009-0004-9782-1944
Amal FahmaCentre for Integrative Omics Data Science (CIODS), Yenepoya (Deemed to be University), Mangalore, Karnataka, India.ORCID https://orcid.org/0009-0008-9745-0679
Althaf MahinCentre for Integrative Omics Data Science (CIODS), Yenepoya (Deemed to be University), Mangalore, Karnataka, India.ORCID https://orcid.org/0009-0007-6017-4415
Leona DcunhaCentre for Integrative Omics Data Science (CIODS), Yenepoya (Deemed to be University), Mangalore, Karnataka, India.ORCID https://orcid.org/0009-0004-2245-9522
Athira Perunelly GopalakrishnanCentre for Integrative Omics Data Science (CIODS), Yenepoya (Deemed to be University), Mangalore, Karnataka, India.ORCID https://orcid.org/0009-0002-1408-9280
Samseera UmmarCentre for Integrative Omics Data Science (CIODS), Yenepoya (Deemed to be University), Mangalore, Karnataka, India.ORCID https://orcid.org/0009-0001-0814-2893
Rajesh RajuCentre for Integrative Omics Data Science (CIODS), Yenepoya (Deemed to be University), Mangalore, Karnataka, India.ORCID https://orcid.org/0000-0003-2319-121X
Sowmya SomanCentre for Integrative Omics Data Science (CIODS), Yenepoya (Deemed to be University), Mangalore, Karnataka, India.ORCID https://orcid.org/0009-0003-1452-2627

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Serine/threonine-protein kinase 10 (STK10), an ERM protein kinase, functions as a membrane-cytoskeleton linker and regulates lymphocyte cortical rigidity, cell shape, adhesion, and migration. Despite its emerging relevance in immune regulation and cancer, the phosphoregulatory mechanisms governing STK10 remain poorly understood. To address this, we systematically assembled and mapped the global phosphoproteomic datasets on the dark STK10 phosphosites. From 453 quantitative differential profiles representing STK10 Class 1 phosphosites, 12 predominant sites were identified based on frequency. Of these, four phosphosites (T185, S191, S514, and T952) were conserved with the homologous kinase SLK, indicating evolutionary conservation. Notably, S450, S455, T14, S448, and S454 were predicted as potential autophosphorylation sites, suggesting intrinsic regulatory control. Predictions indicated that PAK2 and MAP3K2 may act as both upstream kinases and downstream substrates of STK10, with their phosphosites (MAP3K2_S153 and PAK2_S141) consistently co-regulated, suggesting a common regulatory axis. These findings stacked the phosphorylation landscape of STK10, extending regulatory insights beyond its kinase domain. This phosphoproteomics data-driven study establishes a framework for prioritizing functional validation and structural investigations to define the physiological and pathological significance of dark phosphosites in STK10 in immunity and cancer.

Indexed as

Protein Serine-Threonine KinasesAnimalsHumansPhosphoproteinsPhosphorylationProteomicsPhosphoproteinsProtein Serine-Threonine Kinasesco-regulationphosphoproteomicspredominant phosphositesSTK10

Identifiers

PMID42841318
PMCPMC13643830

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.